Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

DaVita (0I7E) Share Price & Analysis

0 Followers

0I7E Stock Chart & Stats

$176.40-$2.79(-1.56%)
At close: 4:30 PM GMT
$175$180$185$190Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$175.74 - $187.52
52-Week Range
$101.01 - $250.00
Previous Close
$179.19
Volume
N/A
Average Volume (3M)
458
Market Cap
$11.54B
Enterprise Value
$25.92B
Total Cash (Recent Filing)
$566.30M
Total Debt (Recent Filing)
$13.39B
Price to Earnings (P/E)
13.5
Beta
0.27
Next Earnings
Feb 11, 2027 (Est.)
EPS Estimate
4.14
Last Dividend Ex-Date
Mar 15, 2022
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Steady Growth And Cash Generation

DaVita combines steady revenue expansion with substantial operating and free cash flow, showing that its core dialysis model remains highly cash generative. This supports ongoing investment in care capabilities, technology and growth initiatives while providing internally generated funding for the business.

Expanded HD Clinical Platform

The expanded HD rollout is a structural clinical initiative supported by broad staff training, compatible equipment and strong pilot adoption. Management expects lower mortality and higher volume growth to begin contributing from late 2028, creating a potential long-term benefit.

Integrated Kidney Care Expansion

IKC is extending DaVita beyond treatment delivery into upstream kidney care and value-based contracts. Improved clinical interventions, shared savings and the Humana expansion can deepen payer relationships, diversify earnings and strengthen the company’s role across the kidney-care pathway.

Bears Say

High Leverage And Negative Equity

The combination of substantial debt and negative shareholders’ equity materially reduces financial flexibility. It leaves DaVita more sensitive to operating shocks, limits room for discretionary capital allocation and increases the importance of sustaining cash generation while managing obligations.

Margin And Cost Pressure

Margin compression indicates that recent revenue growth is not converting into profitability as efficiently as before. Higher patient-care costs, medical supplies and professional liability expenses could continue to weigh on earnings if pricing, productivity and operating improvements do not offset them.

Volume And Reimbursement Headwinds

DaVita remains exposed to modest treatment-volume growth and reimbursement mix pressure because its revenue depends on treatment activity and payer economics. Lower commercial mix, ACA effects and below-historical volume growth can constrain revenue per treatment and limit operating leverage.

DaVita News

0I7E FAQ

What was DaVita’s price range in the past 12 months?
DaVita lowest share price was $101.01 and its highest was $250.00 in the past 12 months.
What is DaVita’s market cap?
DaVita’s market cap is $11.54B.
When is DaVita’s upcoming earnings report date?
DaVita’s next earnings report is estimated for Feb 11, 2027 (not yet confirmed), which is in 90 days.
How were DaVita’s earnings last quarter?
DaVita released its earnings results on Oct 29, 2026. The company reported $3.82 earnings per share for the quarter, beating the consensus estimate of $3.575 by $0.245.
Is DaVita overvalued?
According to Wall Street analysts DaVita’s price is currently Undervalued.
Does DaVita pay dividends?
DaVita pays a dividend of $0.285 which represents an annual dividend yield of ―. See more information on DaVita dividends here
What is DaVita’s EPS estimate?
DaVita’s EPS estimate is 4.14.
How many shares outstanding does DaVita have?
DaVita has 62,900,000 shares outstanding.
What happened to DaVita’s price movement after its last earnings report?
DaVita reported an EPS of $3.82 in its last earnings report, beating expectations of $3.575. Following the earnings report the stock price went down -2.172%.
Which hedge fund is a major shareholder of DaVita?
Hedge funds hold DaVita shares: the largest hedge-fund position in DaVita is 944,474,993 shares, and hedge funds decreased their holdings by 1.6M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology